Additional information
yellow light Powder
1225195-71-0
ACI-020204
73-.9-74.5
C26H40N2O5
460.59
Ambient
2-8°C
Antihypertensive
Pharmaceutical Impurity Standards
1-[4-[4-(2-hydroxy-3-isopropylaminopropoxy) benzyloxylmethyl] phenoxy]- 3-isopropylaminopropan-2-ol
(RS)-1-[4-[4-(2-Hydroxy-3-isopropylaminopropoxy)benzyloxylmethyl] phenoxy]-3-isopropylaminopropan-2-ol
Bisoprolol Ether Dimer Hydrochloride





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)